Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease
Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease
Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease
Submitted by
moderatorj
on October 13, 2011 - 10:15pm
Source:
Yahoo/BusinessWire
News Tags:
Baxter
investigation
research
disease
Headline:
Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease
Do Not Allow Advertisers to Use My Personal information
